TOPU
ADVM

Trustees of Princeton University’s Adverum Biotechnologies ADVM Stock Holding History

Trustees of Princeton University’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$808K Buy
+7,453
New +$922K 1.21% 3

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Trustees of Princeton University's ADVM Position: Q4 2020 in Review

Trustees of Princeton University opened a new position in Adverum Biotechnologies (ADVM) in Q4 2020: 7,453 shares worth $808K. The stake represents 1.21% of the portfolio and ranks #3 among its holdings.

155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Trustees of Princeton University held 7,453 shares of Adverum Biotechnologies worth $808K as of Q4 2020.
  • Adverum Biotechnologies was a new Trustees of Princeton University position in Q4 2020.
  • Adverum Biotechnologies made up 1.21% of Trustees of Princeton University's portfolio in Q4 2020, its #3 holding.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Trustees of Princeton University's 13F filing for Q4 2020, filed 9 Feb 2021.